News
FDA panel: Continue using paclitaxel-eluting PAD devices, with caveats
Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key...
Article
FDA panel to reassess the fate of paclitaxel-coated PAD devices
The FDA is requesting the panel’s input regarding the presence and magnitude of the increased mortality signal and its potential causes.
News
DOPPS participation associated with lower HCV rates in dialysis patients
HCV infection decreased from 2.9 to 1.2 per 100 patient-years in countries participating in the initial phase of DOPPS.
News
Higher serum leptin levels associated with PAD
Serum leptin levels are positively and independently associated with PAD.
News
HCC linked to mitochondrial damage, iron accumulation from HCV
Mitochondrial damage and iron accumulation from HCV are linked to the development of hepatocellular carcinoma.
News
SHM’s Research Shark Tank a resounding success
Shark Tank format highlights research proposals of applicants seeking advice from experts.
